FDA approves Astra Zeneca’s TRUQAP (ca
AstraZeneca’s TRUQAP (New Molecule Capivasertib) in combination with Faslodex (Fulvestrant) has been approved in the
Warning letters, 483s, Recalls, Import Alerts, Audit observations
AstraZeneca’s TRUQAP (New Molecule Capivasertib) in combination with Faslodex (Fulvestrant) has been approved in the
Danish Pharma firm Ascendis Pharma announced the European Commission approval for palopegteriparatide (Yorvipath), for treatment
Bristol Myers Squibb Augtyroâ„¢ (repotrectinib) is approved for treatment of adult patients with ROS1-positive non-small
Vamorolone is a synthetic corticosteroid approved by USFDA for the treatment of Duchenne Muscular Dystrophy
Fabre-Kramer Pharmaceuticals Inc. (Fabre-Kramer), a biopharmaceutical company announced approval of Exxuaâ„¢ (gepirone hydrochloride extended-release tablets)
</a> Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)